Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mortality, significantly reduced by oral anticoagulation. Adherence to guidelines may lower the risks for both all cause and cardiovascular (CV) deaths. Methods: Our objective was to evaluate if antithrombotic prophylaxis according to the 2012 European Society of Cardiology (ESC) guidelines is associated to a lower rate of adverse outcomes. Data were obtained from REPOSI; a prospective observational study enrolling inpatients aged ≥65 years. Patients enrolled in 2012 and 2014 discharged with an AF diagnosis were analysed. Results: Among 2535 patients, 558 (22.0 %) were discharged with a diagnosis of AF. Based on ESC guidelines, 40.9 % of patients were on g...
Background: Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mo...
AIMS: Guideline-adherent therapy for stroke prevention in atrial fibrillation has been associated wi...
Objective: To assess the influence of guideline-adherent vs nonadherent antithrombotic treatment (AT...
Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mortality, sig...
Background: Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mo...
AIMS: Guideline-adherent therapy for stroke prevention in atrial fibrillation has been associated wi...
Objective: To assess the influence of guideline-adherent vs nonadherent antithrombotic treatment (AT...
Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mortality, sig...
Background: Atrial fibrillation (AF) is associated with a substantial risk of thromboembolism and mo...
AIMS: Guideline-adherent therapy for stroke prevention in atrial fibrillation has been associated wi...
Objective: To assess the influence of guideline-adherent vs nonadherent antithrombotic treatment (AT...